Susanne L.
- Country
- Germany
- Department
- KIM II Hämatologie und Intern. Onkologie
Research Overview
Data & Insights
Has run more than one trial at 4 of 117 partner sites.
Specializations
Advanced Lung Cancer Treatment
The investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular focus on personalized therapeutic approaches for metastatic disease.
- Stage III and IV NSCLC management
- Targeted therapies for specific mutations
- Maintenance therapy protocols
Their work encompasses both traditional and innovative treatment methodologies for advanced lung cancer cases.
Molecular-Targeted Therapies
Focuses on precision medicine approaches targeting specific genetic alterations, including ALK-positive NSCLC and KRAS G12C mutations.
- ALK inhibitor therapeutics
- KRAS pathway interventions
- Biomarker-driven treatment selection
Their research explores the effectiveness of targeted therapies in molecularly defined patient populations.
Immunotherapy Innovation
Investigates novel approaches in immunotherapy administration and combinations, particularly focusing on PD-L1 expression and treatment optimization.
- Pembrolizumab delivery methods
- Combination maintenance strategies
- PD-L1 biomarker assessment
Evaluates various immunotherapy delivery methods and combination approaches for optimal patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.